AEON climbs as FDA Type 2b feedback supports a potentially streamlined ABP-450 biosimilar path
Market Chameleon (Wed, 30-Sep 11:36 AM)
AEON Biopharma Strengthens Regulatory Team With FDA Neuroscience Veteran Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
Market Chameleon (Tue, 25-Aug 10:31 AM)
